EMICIZUMAB PROPHYLAXIS IN INFANTS WITH SEVERE HEMOPHILIA A: MANAGEMENT OF 6 CASES

被引：0
|
作者：
Wang, Cassandra [1 ]
Kizilocak, Hande [1 ]
Young, Guy [1 ]
机构：
[1] Childrens Hosp Los Angeles, Ctr Thrombosis & Hemostasis, Los Angeles, CA USA
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
011
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Peri-Procedural Management and Outcomes of Patients with Hemophilia on Emicizumab Prophylaxis
    McCary, Isabella
    Guelcher, Christine
    Kuhn, Jan
    Butler, Regina
    Guerrera, Michael F.
    Massey, Gita
    Raffini, Leslie J.
    BLOOD, 2019, 134
  • [22] Emicizumab Prophylaxis in Patients with Severe Hemophilia A: Insights from A Resource Limited Country
    Borhany, Munira
    Arshad, Aisha
    Qureshi, Heeba
    Nadeem, Rukhshanda
    Jamal, Arif
    Khan, Raheel Ahmed
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2024, 30
  • [23] Maintaining Perioperative Hemostasis in Patients with Severe Hemophilia A and Inhibitors Receiving Emicizumab Prophylaxis
    Zimowski, Karen L.
    Batsuli, Glaivy M.
    Reding, Mark T.
    Rana, Jatin
    Callaghan, Michael U.
    Tickle, Kelly
    Meeks, Shannon L.
    Sidonio, Robert F., Jr.
    BLOOD, 2018, 132
  • [24] Health-related quality of life in children with severe hemophilia A on emicizumab prophylaxis
    Hassan, Ahmed S.
    Sherief, Laila M.
    Hamdy, Mona
    Abbas, Ahmed M.
    Elagamy, Osama
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2024, 49 (02): : 192 - 196
  • [25] Two pediatric cases of severe hemophilia A in which emicizumab prophylaxis failed to prevent traumatic extra-articular hemorrhage
    Yuya Yamada
    Yuto Nakajima
    Ayaka Ohara
    Emi Wakita
    Kazuki Shimizu
    Naruto Shimonishi
    Shoko Furukawa
    Kenichi Ogiwara
    Masahiro Takeyama
    Keiji Nogami
    International Journal of Hematology, 2023, 117 : 607 - 612
  • [26] Two pediatric cases of severe hemophilia A in which emicizumab prophylaxis failed to prevent traumatic extra-articular hemorrhage
    Yamada, Yuya
    Nakajima, Yuto
    Ohara, Ayaka
    Wakita, Emi
    Shimizu, Kazuki
    Shimonishi, Naruto
    Furukawa, Shoko
    Ogiwara, Kenichi
    Takeyama, Masahiro
    Nogami, Keiji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (04) : 607 - 612
  • [27] Emicizumab Prophylaxis in Infants with Severe Hemophilia A without Factor VIII Inhibitors: Results from the Primary Analysis of the HAVEN 7 Study
    Pipe, Steven
    Collins, Peter
    Dhalluin, Christophe
    Kenet, Gili
    Schmitt, Christophe
    Buri, Muriel
    Jimenez-Yuste, Victor
    Peyvandi, Flora
    Young, Guy
    Oldenburg, Johannes
    Mancuso, Maria Elisa
    Kavakli, Kaan
    Kiialainen, Anna
    Chang, Tiffany
    Lehle, Michaela
    Niggli, Markus
    Fijnvandraat, Karin
    BLOOD, 2023, 142
  • [28] COST-CONSEQUENCE ANALYSIS OF EMICIZUMAB PROPHYLAXIS FOR SEVERE HEMOPHILIA A PATIENTS WITHOUT INHIBITORS
    Cortesi, P. A.
    Castaman, G.
    Mantovani, L. G.
    VALUE IN HEALTH, 2020, 23 : S696 - S696
  • [29] Prevention of Bleeding in Patients with Moderate and Severe Hemophilia A Playing Sports: A Comparison between Factor VIII and Emicizumab Prophylaxis (STEP: SporTs Emicizumab Prophylaxis)
    Chitlur, Meera B.
    BLOOD, 2022, 140 : 5619 - 5620
  • [30] Emicizumab prophylaxis in a Korean child with severe hemophilia A and high titer inhibitor: a case report
    Ahn, Ji Hyun
    Jung, Nani
    Shim, Ye Jee
    Kim, Heung Sik
    BLOOD RESEARCH, 2021, 56 (01) : 44 - 46
12345